Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First revision.

Forny, Patrick; Hörster, Friederike; Ballhausen, Diana; Chakrapani, Anupam; Chapman, Kimberly A; Dionisi-Vici, Carlo; Dixon, Marjorie; Grünert, Sarah C; Grunewald, Stephanie; Haliloglu, Goknur; Hochuli, Michel; Honzik, Tomas; Karall, Daniela; Martinelli, Diego; Molema, Femke; Sass, Jörn Oliver; Scholl-Bürgi, Sabine; Tal, Galit; Williams, Monique; Huemer, Martina; ... (2021). Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First revision. Journal of inherited metabolic disease, 44(3), pp. 566-592. Wiley 10.1002/jimd.12370

[img]
Preview
Text
J_of_Inher_Metab_Disea_-_2021_-_Forny_-_Guidelines_for_the_diagnosis_and_management_of_methylmalonic_acidaemia_and.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (4MB) | Preview

Isolated methylmalonic acidaemia (MMA) and propionic acidaemia (PA) are rare inherited metabolic diseases. Six years ago, a detailed evaluation of the available evidence on diagnosis and management of these disorders has been published for the first time. The article received considerable attention, illustrating the importance of an expert panel to evaluate and compile recommendations to guide rare disease patient care. Since that time, a growing body of evidence on transplant outcomes in MMA and PA patients and use of precursor free amino acid mixtures allows for updates of the guidelines. In this article, we aim to incorporate this newly published knowledge and provide a revised version of the guidelines. The analysis was performed by a panel of multidisciplinary health care experts, who followed an updated guideline development methodology (GRADE). Hence, the full body of evidence up until autumn 2019 was re-evaluated, analysed and graded. As a result, 21 updated recommendations were compiled in a more concise paper with a focus on the existing evidence to enable well-informed decisions in the context of MMA and PA patient care.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition

UniBE Contributor:

Hochuli, Michel

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1573-2665

Publisher:

Wiley

Language:

English

Submitter:

Laura Cavalli

Date Deposited:

25 Jan 2022 15:24

Last Modified:

05 Dec 2022 16:03

Publisher DOI:

10.1002/jimd.12370

PubMed ID:

33595124

Uncontrolled Keywords:

diagnosis and management guidelines inherited metabolic disease methylmalonic acidaemia propionic acidaemia

BORIS DOI:

10.48350/164266

URI:

https://boris.unibe.ch/id/eprint/164266

Actions (login required)

Edit item Edit item
Provide Feedback